RxDoctor Payments Data

Christopher Apostol, DO

Family Medicine · Evans, GANPI 1750383626

Payments from drug & device makers

$2,032in general payments, 2019–2025

Across 46 payments — averaging $44.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sekisui Diagnostics LLC$1K
  • Pfizer$236
  • GSK$165
  • Boston Scientific$119
  • Merck$50
  • Exact Sciences$44
  • plus $113 from 6 others

What the payments were for

  • Food & beverage$72736%
  • Gifts$1,30564%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sekisui Diagnostics LLC4$1,305
Pfizer14$236
GSK11$165
Boston Scientific5$119
Merck3$50
Exact Sciences3$44
Lundbeck LLC1$26
Sanofi Pasteur Inc.1$21
Medtronic1$18
Linus Health, Inc.1$18
Stryker1$16
Corcept Therapeutics1$14

How this compares

$2,032 in reported general payments places this provider in the 70th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$303,907
Medicare patients
665
Services billed
8,168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin135$182,411
EliquisApixaban117$109,277
JanuviaSitagliptin Phosphate99$93,694
ArexvyRsvpref3 Antigen/As01e/Pf304$92,555
RybelsusSemaglutide38$77,264
OzempicSemaglutide65$72,595
XareltoRivaroxaban43$41,087
JanumetSitagliptin Phos/Metformin Hcl27$28,226
FarxigaDapagliflozin Propanediol22$24,760
ShingrixVaricella-Zoster Ge/As01b/Pf97$21,541
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog52$16,630
EntrestoSacubitril/Valsartan26$12,737
Soliqua 100-33Insulin Glargine/Lixisenatide14$9,779
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$9,362
Tresiba Flextouch U-100Insulin Degludec18$9,320

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKArexvy, Shingrix, Trelegy Ellipta$165$123,458415 claims
MerckJanuvia, Janumet$50$121,920126 claims
PfizerEliquis$236$109,277117 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Evans

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →